Companies
- Companies
- Company details
Helix BioMedix
Bioactive peptides for pharmaceutical and device marketsThe company in detail
Summary
Founded in 1988, Helix BioMedix, is a public biopharmaceutical company focusing on the discovery, synthesis and commercialization of novel, bioactive lytic peptides proprietarily termed Cytoporins.
R&D
To view this information, you must subscribe to Pharmalicensing Intelligence.
Partnerships
To view this information, you must subscribe to Pharmalicensing Intelligence.
Deals
To view this information, you must subscribe to Pharmalicensing Intelligence.
Senior management
To view this information, you must subscribe to Pharmalicensing Intelligence.
Board of directors
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2011 - 43 pages - $500
Nov 2010 - 50 pages - $500
Feb 2011 - 29 pages - $125
Nov 2010 - 118 pages - $600
May 2011 - 36 pages - $125
Nov 2010 - 34 pages - $750
Oct 2010 - 24 pages - $125
May 2011 - 15 pages - $125
Mar 2011 - 32 pages - $125
Jun 2011 - 40 pages - $125
Contact details
To view this information, you must subscribe to Pharmalicensing Intelligence.
Head office
Related companies
Related categories
- Industry sector
- Biotechnology
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Therapeutic target
- Dermatological
- Dermatological / Acne
- Dermatological / Fungal infection
- Dermatological / Psoriasis
- Dermatological / Bacterial infection
- Dermatological / Dermatitis, atopic
- Dermatological / Wound healing
- Hospital and Surgery
- Infectious diseases
- Other therapeutic
- Respiratory
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us